Literature DB >> 27091928

Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma.

Brahmchetna Bedi1,2, Zhihong Yuan1,2, Myungsoo Joo3, Susu M Zughaier1,4, Joanna B Goldberg5, Jack L Arbiser1,6, C Michael Hart1,2, Ruxana T Sadikot7,2.   

Abstract

The pathogenic profile of Pseudomonas aeruginosa is related to its ability to secrete a variety of virulence factors. Quorum sensing (QS) is a mechanism wherein small diffusible molecules, specifically acyl-homoserine lactones, are produced by P. aeruginosa to promote virulence. We show here that macrophage clearance of P. aeruginosa (PAO1) is enhanced by activation of the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARγ). Macrophages treated with a PPARγ agonist (pioglitazone) showed enhanced phagocytosis and bacterial killing of PAO1. It is known that PAO1 QS molecules are inactivated by PON-2. QS molecules are also known to inhibit activation of PPARγ by competitively binding PPARγ receptors. In accord with this observation, we found that infection of macrophages with PAO1 inhibited expression of PPARγ and PON-2. Mechanistically, we show that PPARγ induces macrophage paraoxonase 2 (PON-2), an enzyme that degrades QS molecules produced by P. aeruginosa Gene silencing studies confirmed that enhanced clearance of PAO1 in macrophages by PPARγ is PON-2 dependent. Further, we show that PPARγ agonists also enhance clearance of P. aeruginosa from lungs of mice infected with PAO1. Together, these data demonstrate that P. aeruginosa impairs the ability of host cells to mount an immune response by inhibiting PPARγ through secretion of QS molecules. These studies define a novel mechanism by which PPARγ contributes to the host immunoprotective effects during bacterial infection and suggest a role for PPARγ immunotherapy for P. aeruginosa infections.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27091928      PMCID: PMC4936346          DOI: 10.1128/IAI.00164-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  75 in total

1.  A component of innate immunity prevents bacterial biofilm development.

Authors:  Pradeep K Singh; Matthew R Parsek; E Peter Greenberg; Michael J Welsh
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Fate PPAR-titioning: PPAR-γ 'instructs' alveolar macrophage development.

Authors:  Florent Ginhoux
Journal:  Nat Immunol       Date:  2014-11       Impact factor: 25.606

4.  Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages.

Authors:  Mansoor Ali Syed; M Joo; Zulfiqar Abbas; D Rodger; J W Christman; D Mehta; R T Sadikot
Journal:  Exp Cell Res       Date:  2010-08-24       Impact factor: 3.905

Review 5.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

Authors:  Ruxana T Sadikot; Timothy S Blackwell; John W Christman; Alice S Prince
Journal:  Am J Respir Crit Care Med       Date:  2005-02-01       Impact factor: 21.405

6.  The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.

Authors:  Tammy Kielian; Mohsin Md Syed; Shuliang Liu; Nirmal K Phulwani; Napoleon Phillips; Gail Wagoner; Paul D Drew; Nilufer Esen
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

7.  Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.

Authors:  Dai-Shun Liu; Wei-Jia Liu; Lei Chen; Xue-Mei Ou; Tao Wang; Yu-Lin Feng; Shang-Fu Zhang; Dan Xu; Ya-Juan Chen; Fu-Qiang Wen
Journal:  Toxicology       Date:  2009-04-05       Impact factor: 4.221

8.  Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages.

Authors:  Susu M Zughaier; Justin L Kandler; William M Shafer
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 9.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

10.  Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Phoebe E Griffin; Louise F Roddam; Yvonne C Belessis; Roxanne Strachan; Sean Beggs; Adam Jaffe; Margaret A Cooley
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more
  14 in total

1.  Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.

Authors:  Brahmchetna Bedi; Nicholas M Maurice; Vincent T Ciavatta; K Sabrina Lynn; Zhihong Yuan; Samuel A Molina; Myungsoo Joo; William R Tyor; Joanna B Goldberg; Michael Koval; C Michael Hart; Ruxana T Sadikot
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

Review 2.  Immunometabolism at the interface between macrophages and pathogens.

Authors:  David G Russell; Lu Huang; Brian C VanderVen
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

3.  Use of oral anti-diabetic drugs and risk of hospital and intensive care unit admissions for infections.

Authors:  Jeeyon Rim; Julia Gallini; Christine Jasien; Xiangqin Cui; Lawrence Phillips; Aaron Trammell; Ruxana T Sadikot
Journal:  Am J Med Sci       Date:  2022-01-22       Impact factor: 3.462

4.  PPARγ-activation increases intestinal M1 macrophages and mitigates formation of serrated adenomas in mutant KRAS mice.

Authors:  Tobias Gutting; Christian A Weber; Philip Weidner; Frank Herweck; Sarah Henn; Teresa Friedrich; Shuiping Yin; Julia Kzhyshkowska; Timo Gaiser; Klaus-Peter Janssen; Wolfgang Reindl; Matthias P A Ebert; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

Review 5.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

6.  UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Brahmchetna Bedi; Kuo-Chuan Lin; Nicholas M Maurice; Zhihong Yuan; Kaiser Bijli; Michael Koval; C Michael Hart; Joanna B Goldberg; Arlene Stecenko; Ruxana T Sadikot
Journal:  Clin Sci (Lond)       Date:  2020-07-31       Impact factor: 6.124

Review 7.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

8.  PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.

Authors:  Lucy D Burr; Geraint B Rogers; Alice C-H Chen; Steven L Taylor; Simon D Bowler; Rebecca L Keating; Megan L Martin; Sumaira Z Hasnain; Michael A McGuckin
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

9.  Long non-coding RNA LINC00488 facilitates thyroid cancer cell progression through miR-376a-3p/PON2.

Authors:  Fuyuan Xie; Longgen Li; Yuting Luo; Rensheng Chen; Jinhong Mei
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

10.  Macrophages exposed to HIV viral protein disrupt lung epithelial cell integrity and mitochondrial bioenergetics via exosomal microRNA shuttling.

Authors:  Zhihong Yuan; Jessica R Petree; F Eun-Hyung Lee; Xian Fan; Khalid Salaita; David M Guidot; Ruxana T Sadikot
Journal:  Cell Death Dis       Date:  2019-08-02       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.